High-dose cyclophosphamide treatment for refractory severe aplastic anemia in children-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-dose cyclophosphamide treatment for refractory severe aplastic anemia in children

Published:2009-10-13 Issue:2 Volume:54 Page:269-272
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Audino Anthony N.,Blatt Julie,Carcamo Benjamin,Castaneda Victoria,Dinndorf Patricia,Wang Winfred C.,Whitlock James A.,Hord Jeffrey D.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.22312/fullpdf

Reference25 articles.

1. Current concepts in the pathophysiology and treatment of aplastic anemia;Young;Blood,2006

2. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine;Scheinberg;J Pediatr,2008

3. Aplastic anemia (second of two parts): Pathogenesis, diagnosis, treatment, and prognosis;Camitta;N Engl J Med,1982

4. The mortality of acquired aplastic anemia in children;Li;Blood,1972

5. Current status of allogeneic bone marrow transplantation in acquired aplastic anemia;Horowitz;Semin Hematol,2000

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of relapsed/refractory severe aplastic anemia in children: Evidence‐based recommendations;Pediatric Blood & Cancer;2024-05-19

2. High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia;Journal of Pediatric Hematology/Oncology;2016-11

3. Immunosuppressive therapy for transplant-ineligible aplastic anemia patients;Expert Review of Hematology;2015-01-02

4. Rabbit Antithymocyte Globulin Treatment in Childhood Acquired Severe Aplastic Anemia;Pediatric Hematology and Oncology;2013-04-30

5. Rabbit-antithymocyte globulin combined with cyclosporin A as a first-line therapy: improved, effective, and safe for children with acquired severe aplastic anemia;Journal of Cancer Research and Clinical Oncology;2012-03-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3